Effects of Opicapone on Liver Function and Monitoring Suggestions

Opicapone is a third-generation catechol-O-methyltransferase (COMT) inhibitor, which is commonly used in combined treatment with levodopa in patients with Parkinson's disease to prolong the therapeutic effect of levodopa. As a long-term oral small molecule drug, although opicapone is generally well tolerated in clinical practice, its potential impact on liver function still requires attention.

According to existing research and data from regulatory agencies, although Opicapone has a lower risk of hepatotoxicity than earlier COMT inhibitors (such as tolcapone), it is still recommended to monitor liver function during the initial and during use to prevent rare but potentially serious liver adverse events.

Opicapone is primarily metabolized by the liver, so patients with abnormal liver function should receive adequate evaluation before use. In particular, people with moderate to severe hepatic insufficiency (such as Child-Pugh class B or C) are generally advised to avoid using this drug. In addition, if the patient develops abnormal liver function symptoms such as significantly elevated transaminases, jaundice, fatigue, or right upper quadrant discomfort during treatment, the liver enzyme levels need to be rechecked immediately, and the dose should be adjusted or the drug discontinued as appropriate. It is recommended to regularly detect ALT, AST, bilirubin and other indicators in the first month after starting treatment and every 3 months thereafter.

Clinicians should obtain the patient's past liver history when prescribing opicapone and avoid concomitant use with other known hepatotoxic drugs. At the same time, patients are reminded to take medications regularly and pay attention to self-identification of liver symptoms, which can help detect potential problems early.

In general, although the probability of severe liver injury caused by Opicapone is low, standardized liver function monitoring can significantly improve medication safety and is the basis for precise medication.

Reference materials:https://www.ongentys.com/